Stem cells news, articles and features | New Scientist /topic/stem-cells/ Science news and science articles from New Scientist Wed, 20 May 2026 14:18:28 +0000 en-US hourly 1 https://wordpress.org/?v=7.0.1 242057827 Rebooting stem cells builds aged muscles and assists injury recovery /article/2526626-rebooting-stem-cells-builds-aged-muscles-and-assists-injury-recovery/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Thu, 14 May 2026 09:00:21 +0000 /?post_type=article&p=2526626 2526626 Is stem cell therapy about to transform medicine and reverse ageing? /article/2524182-is-stem-cell-therapy-about-to-transform-medicine-and-reverse-ageing/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Fri, 24 Apr 2026 08:00:12 +0000 /?post_type=article&p=2524182 2524182 Frailty can be eased with an infusion of stem cells from young people /article/2517139-frailty-can-be-eased-with-an-infusion-of-stem-cells-from-young-people/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Fri, 27 Feb 2026 15:00:43 +0000 /?post_type=article&p=2517139 2517139 Man unexpectedly cured of HIV after stem cell transplant /article/2506595-man-unexpectedly-cured-of-hiv-after-stem-cell-transplant/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Mon, 01 Dec 2025 16:00:14 +0000 /?post_type=article&p=2506595 HIV infected 293T cell.
An HIV-infected human cell
STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY

A man has become the seventh person to be left HIV-free after receiving a stem cell transplant to treat blood cancer. Significantly, he is also the second of the seven who received stem cells that were not actually resistant to the virus, strengthening the case that HIV-resistant cells may not be necessary for an HIV cure.

鈥淪eeing that a cure is possible without this resistance gives us more options for curing HIV,鈥 says at the Free University of Berlin.

Five people have previously become free of HIV after receiving stem cells from donors who carried a mutation in both copies of a gene encoding a protein called CCR5, which HIV uses to infect immune cells. This led scientists to conclude that having two copies of the mutation, which completely removes CCR5 from immune cells, was crucial for curing HIV. 鈥淭he belief was that using these HIV-resistant stem cells was essential,鈥 says Gaebler.

But last year a sixth person 鈥 known as the 鈥淕eneva patient鈥 鈥 was for more than two years after receiving stem cells without the CCR5 mutation, suggesting CCR5 isn鈥檛 the whole story 鈥 although many scientists think the roughly two-year virus-free period isn鈥檛 quite long enough to show they were actually cured, says Gaebler.

The latest case strengthens the idea that the Geneva patient has been cured. It involves a man who, in October 2015, received stem cells to treat leukaemia, a type of blood cancer where immune cells grow uncontrollably. The man, who was aged 51 at the time, had HIV. During his treatment, he was given chemotherapy to destroy the vast majority of his immune cells, making room for the donor stem cells to produce a healthy immune system.

Ideally, the man would have received HIV-resistant stem cells, but these weren鈥檛 available, so doctors used cells that carried one typical and one mutated copy of the CCR5 gene. At the time, the man was taking a standard HIV therapy called antiretroviral therapy (ART), a combination of drugs that suppress the virus to undetectable levels, meaning it can鈥檛 be passed on to other people 鈥 and reducing the risk that the donor cells would be infected.

But about three years after the transplant, he chose to stop taking ART. 鈥淗e felt that he鈥檇 waited some time after the stem cell transplant, he was in remission for the cancer, and he was always feeling that the transplant would work,鈥 says Gaebler.

Shortly after, the team found no signs of the virus in blood samples from the man. He has since remained free of the virus for seven years and three months, enough for him to be considered 鈥渃ured鈥. He has had no detectable HIV in his body for the second longest period of the seven people declared free of the virus 鈥 with the longest case being HIV-free for about 12 years. 鈥淚t鈥檚 amazing that 10 years ago his chances of dying of cancer were extremely high and now he鈥檚 overcome this deadly diagnosis, a persistent viral infection and he鈥檚 not taking any medications 鈥 he鈥檚 healthy,鈥 says Gaebler.

The discovery upends our understanding of what鈥檚 required for curing HIV via this approach. 鈥淲e thought you needed to transplant from donors that lack CCR5 鈥 it turns out that you don鈥檛,鈥 says at the University of Cambridge, who wasn鈥檛 involved in the study.

Scientists have generally thought that such cures relied on any virus lurking in the recipient鈥檚 remaining immune cells 鈥 following chemotherapy 鈥 being unable to infect the donor cells, meaning it can鈥檛 replicate. 鈥淓ssentially, the pool of host cells to infect runs dry,鈥 says Gaebler.

But the latest case suggests that, instead, cures can be achieved as long as non-resistant donor cells are able to destroy any of the patient鈥檚 remaining original immune cells before the virus can spread to them, speculates Gaebler. Such immune reactions are often driven by differences in the proteins displayed on the two sets of cells. These make the donor cells recognise residual recipient cells as a threat to eliminate, says Gaebler.

The findings suggest that a wider pool of stem cell transplants than we thought 鈥 including those without two copies of the CCR5 mutation 鈥 could potentially cure HIV, says Gaebler.

But it is likely that many factors, such as the recipient鈥檚 and donor鈥檚 genetics, need to align in order for this to work, so that, for instance, the donor鈥檚 cells can rapidly destroy the recipient鈥檚. What鈥檚 more, in the latest case, the man carried one copy of the CCR5 mutation, which could have altered how his immune cells were spread across the body in a way that made it easier to cure him of the virus, says Gaebler.

This means that most people receiving stem cell transplants for HIV and blood cancer should be offered HIV-resistant stem cells where possible, says Gaebler.

It鈥檚 also important to point out that cancer-free people with HIV won鈥檛 benefit from stem cell transplants, as it鈥檚 a very risky procedure that can lead to life-threatening infections, says Gaebler. Most people are better off taking ART 鈥 often in the form of daily pills 鈥 which is a much safer and convenient way to stop HIV from spreading, enabling people to enjoy long and healthy lives, he says. Moreover, a recently available drug called lenacapavir provides .

Nonetheless, efforts are being made to cure HIV by genetically editing immune cells, and prevent it using vaccines.

Journal reference:

Nature

]]>
2506595
Stem cell therapy lowers risk of heart failure after a heart attack /article/2502081-stem-cell-therapy-lowers-risk-of-heart-failure-after-a-heart-attack/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Wed, 29 Oct 2025 23:30:31 +0000 /?post_type=article&p=2502081 2502081 How regrowing your own teeth could replace dentures and implants /article/2487555-how-regrowing-your-own-teeth-could-replace-dentures-and-implants/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Tue, 22 Jul 2025 15:00:26 +0000 /?post_type=article&p=2487555 2487555 Cord blood banking is not living up to its promise /article/2481776-cord-blood-banking-is-not-living-up-to-its-promise/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Mon, 26 May 2025 14:00:57 +0000 /?post_type=article&p=2481776 2481776 Muscle patch made from stem cells could treat heart failure /article/2465942-muscle-patch-made-from-stem-cells-could-treat-heart-failure/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Wed, 29 Jan 2025 16:00:52 +0000 /?post_type=article&p=2465942 2465942 Your ears and nose are made from tissue that looks like bubble wrap /article/2463493-your-ears-and-nose-are-made-from-tissue-that-looks-like-bubble-wrap/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Thu, 09 Jan 2025 19:00:28 +0000 /?post_type=article&p=2463493
These bubble-wrap cartilage cells have been dyed green to make them easily visible
Plikus lab/University of California/Irvine
A long-overlooked skeletal tissue found in the nose and ears turns out to resemble bubble wrap 鈥 and harnessing it could make facial surgery, like nose reshaping, easier. at the University of California, Irvine, and his colleagues first spotted the unusual tissue a few years ago while they were studying fat cells collected from mouse ears. 鈥淚t was just a scientific accident,鈥 he says. The nose and ears of both mice and humans contain a firm but flexible tissue called cartilage, which is also found in our joints. Conventional wisdom says that cartilage is structured similarly, no matter where it is in the body. The cells in it don鈥檛 contain much fat and are surrounded by a thick, protein-rich matrix that provides strength. But when the researchers examined mouse nose and ear samples under a microscope, they found a structure consisting of cells packed full of fats, also known as lipids, connected only by a thin mesh of protein 鈥 prompting the team to name it lipocartilage. 鈥淚t looks like bubble wrap,鈥 says Plikus. This unusual cartilage had been noticed before, the team found, but only in a brief account of its discovery from the 1850s and a few short reports since then. To investigate further, the researchers stretched and squeezed samples of lipocartilage from the mouse ears, and did the same for standard cartilage from the knees and ribs of mice. They found that lipocartilage is softer and more stretchy, probably due to its high fat content, says Plikus. This suggests lipocartilage has unique roles in the body compared with standard cartilage, though identifying these requires further study, he says.
The team also found lipocartilage in human ear and nose samples collected from medically aborted fetuses,聽leading them to wonder whether the tissue could be grown in the lab for use in reconstructive or cosmetic surgery. Nose alterations, for example, sometimes involve taking a piece of cartilage from a person鈥檚 rib. Growing it from stem cells instead could avoid this, but attempts to do so for standard cartilage have been hampered by the difficulty of screening out any remaining stem cells, says Plikus, which, if implanted, could develop into tumours. The researchers found that they could successfully grow lipocartilage from human stem cells derived from embryos, and that it was much easier to spot leftover stem cells using a dye that attaches to the fat in the tissue. It is too early to tell how well this will work in practice until the findings are replicated and the approach is tested in animals and humans, says at the University of Montana, who wasn鈥檛 involved in the study. Plikus鈥檚 team is already carrying out facial implant tests with stem-cell derived lipocartilage in mice and hopes to trial it in humans soon. 鈥淚f we鈥檙e optimistic, within a span of five years,鈥 he says.
Journal reference:

Science

]]>
2463493
From enshittocene to virome, science and technology’s words of 2024 /article/2459279-from-enshittocene-to-virome-science-and-technologys-words-of-2024/?utm_campaign=RSS|NSNS&utm_content=stem-cells&utm_medium=RSS&utm_source=NSNS Wed, 11 Dec 2024 18:00:00 +0000 http://mg26435213.000 2459279